Xeltis announced today that it completed enrollment in an EU pivotal trial for aXess, its restorative vascular access conduit ...
Endologix announced today that President and CEO Dr. Matt Thompson intends to step down and take on a new role.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback